Regulators were unable to determine whether the cause of their illness was the peptides themselves or whether they had been contaminated
Its also known to support muscle growth and enhance overall metabolic health
Chronic exposure data in any species is insufficient to draw conclusions about carcinogenicity, organ toxicity, or endocrine disruption from prolonged BPC-157 administration
Its going to tamper that aspect down, so to speak
Early findings highlight its potential ability to: Protect the mucosal lining Reduce inflammation markers Support vascular and tissue recovery But outcomes vary, and human studies are still ongoing
ERYTHROPOIETINS (EPO) AND AGENTS AFFECTING ERYTHROPOIESIS, INCLUDING, BUT NOT LIMITED TO: S2.1.1 ERYTHROPOIETIN-RECEPTOR AGONISTS, E.G